Sylvain Garciaz

23
Documents

Présentation

Assistant Professor (Hematology / CRCM-Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes)

Publications

3
4
3
2
1
3
1
3
1
2
3
3
3
2
2
2
1
1
1
1
1
1
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Publications

Ivosidenib in refractory or relapsed IDH1-mutated Acute Myeloid Leukemia patients in real life settings: The ivoobs observational study from the french AML intergroup ALFA/filo

Mael Heiblig , Pierre Peterlin , Stéphane Morisset , Pierre-Yves Dumas , Marie Sebert et al.

Blood, 2025, 146 (Supplement 1), pp.3455-3455. ⟨10.1182/blood-2025-3455⟩

Article dans une revue hal-05413650v1

Real life study of ivosidenib in either monotherapy or combined with azacytidine for first line mutant IDH1 AML: A study from the french AML intergroup ALFA/filo

Pierre Peterlin , Mael Heiblig , Stéphane Morisset , Sarah Bertoli , Marie Sebert et al.

Blood, 2025, 146 (Supplement 1), pp.1658-1658. ⟨10.1182/blood-2025-1658⟩

Article dans une revue hal-05413216v1

The addition of a tyrosine kinase inhibitor to intensive chemotherapy significantly improves outcome in de novo BCR::ABL1+ acute myeloid leukemia treated with intensive chemotherapy

Sarah Bertoli , Niklas Landberg , Emilie Bérard , Camille Gondran , Laetitia Largeaud et al.

Blood, 2025, 146 (Supplement 1), pp.991-991. ⟨10.1182/blood-2025-991⟩

Article dans une revue hal-05413744v1
Deposit thumbnail

Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment

Sylvain Garciaz , Pierre‐yves Dumas , Sarah Bertoli , David Sallman , Justine Decroocq et al.

American Journal of Hematology, 2024, 99 (10), pp.1870-1876. ⟨10.1002/ajh.27417⟩

Article dans une revue hal-04916306v1
Deposit thumbnail

Venetoclax Resistance in Acute Myeloid Leukemia

Sylvain Garciaz , Marie-Anne Hospital , Yves Collette , Norbert Vey

Cancers, 2024, 16 (6), pp.1091. ⟨10.3390/cancers16061091⟩

Article dans une revue hal-04945122v1
Deposit thumbnail

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1 -mutant AML

Jan Philipp Bewersdorf , Shai Shimony , Rory Shallis , Yiwen Liu , Guillaume Berton et al.

Blood Advances, 2024, 8 (18), pp.4845-4855. ⟨10.1182/bloodadvances.2024012858⟩

Article dans une revue hal-05141669v1

Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death

Sylvain Garciaz , Andrew Guirguis , Sebastian Müller , Fiona Brown , Yih-Chih Chan et al.

Cancer Discovery, 2023

Article dans une revue hal-05344093v1

Downregulation of stromal syntenin sustains AML development

Raphael Leblanc , Rania Ghossoub , Armelle Goubard , Rémy Castellano , Joanna Fares et al.

EMBO Molecular Medicine, 2023, 15 (11), ⟨10.15252/emmm.202317570⟩

Article dans une revue hal-04532862v1

Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome

Samia Harbi , Louison Brac de la Perriere , Benjamin Bouchacourt , Sylvain Garciaz , Thomas Pagliardini et al.

Bone Marrow Transplantation, 2023, 59 (1), pp.101-106. ⟨10.1038/s41409-023-02134-w⟩

Article dans une revue hal-04957221v1
Deposit thumbnail

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients

Sylvain Garciaz , Marie-Anne Hospital , Anne-Sophie Alary , Colombe Saillard , Yosr Hicheri et al.

Cancers, 2022, 14 (8), pp.2025. ⟨10.3390/cancers14082025⟩

Article dans une revue hal-03665761v1

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Domitille Costes-Tertrais , Thomas Hueso , Thomas Gastinne , Catherine Thieblemont , Lucie Oberic et al.

Bone Marrow Transplantation, 2022, 57 (4), pp.627-632. ⟨10.1038/s41409-022-01596-8⟩

Article dans une revue hal-03608256v1
Deposit thumbnail

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.

Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩

Article dans une revue hal-03376715v1
Deposit thumbnail

Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF

Sylvain Garciaz , Patrick Sfumato , Angela Granata , Anne-Marie Imbert , Claire Fournel et al.

PLoS ONE, 2020, 15 (3), pp.e0228878. ⟨10.1371/journal.pone.0228878⟩

Article dans une revue inserm-02526607v1

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Thomas Hueso , Thomas Gastinne , Sylvain Garciaz , Emmanuelle Tchernonog , Caroline Delette et al.

Bone Marrow Transplantation, 2020, 55 (6), pp.1076-1084. ⟨10.1038/s41409-020-0783-y⟩

Article dans une revue hal-02500667v1
Deposit thumbnail

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation

Sylvain Garciaz , Lia N’guyen Dasi , Pascal Finetti , Christine Chevalier , Julien Vernerey et al.

Clinical Epigenetics, 2019, 11 (1), ⟨10.1186/s13148-019-0738-6⟩

Article dans une revue hal-02322283v1
Deposit thumbnail

Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity

Myriam Koubi , Mathilde Poplineau , Julien Vernerey , Lia N 'Guyen , Guillaume Tiberi et al.

Nucleic Acids Research, 2018, 46 (7), pp.3339-3350. ⟨10.1093/nar/gky080⟩

Article dans une revue hal-01765664v1

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi , Julia Gilhodes , Marie Maerevoet , Charles Herbaux , Franck Morschhauser et al.

American Journal of Hematology, 2018, 93 (8), pp.1042-1049. ⟨10.1002/ajh.25154⟩

Article dans une revue hal-02050402v1

Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers

Sylvain Chantepie , Sylvain Garciaz , Emmanuelle Tchernonog , Frederic Peyrade , Marie-Virginie Larcher et al.

American Journal of Hematology, 2018, 93 (6), pp.729 - 735. ⟨10.1002/ajh.25077⟩

Article dans une revue hal-01860419v1
Deposit thumbnail

Patients’ Non-Medical Characteristics Contribute to Collective Medical Decision-Making at Multidisciplinary Oncological Team Meetings

Restivo Lea , Thémis Apostolidis , Anne Deborah Bouhnik , Sylvain Garciaz , Thérèse Aurran et al. Article dans une revue hal-01457098v1

Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites

Emilie Mamessier , C. Drevet , F. Broussais-Guillaumot , M.-L. Mollichella , S. Garciaz et al.

Haematologica, 2015, 100 (4), pp.e155-e157. ⟨10.3324/haematol.2014.115782⟩

Article dans une revue hal-03606410v1
Deposit thumbnail

Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites

Emilie Mamessier , Charlotte Drevet , Florence Broussais-Guillaumot , Marie-Laure Mollichella , Sylvain Garciaz et al.

Haematologica, 2015, 100, pp.E155-E157

Article dans une revue hal-01216319v1

Deciphering EZH2 Non-Canonical Activities in AML Resistance

Lia N'Guyen , Emeline Boet , Camille Montersino , Claire Burny , Stéphane Audebert et al.

The 66th ASH Annual Meeting, Dec 2024, San Diego (CA), United States. 144 (Supplement 1), pp.4097-4097, 2024, ⟨10.1182/blood-2024-200580⟩

Poster de conférence hal-05390918v1